Erbium:YAG Laser Pretreatment Accelerates the Response of Bowen's Disease Treated by Topical 5-Fluorouracil

Dermatologic Surgery

Volumn 30, Issue 3, 2004, Pages 441-445

  Wang, Kuo Hsien ^a,c   Fang, Jia You ^b   Hu, Chung Hong ^a,c   Lee, Woan Ruoh ^c,d  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL;

ADULT; ARTICLE; BOWEN DISEASE; CASE REPORT; CREAM; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG RESPONSE; ERBIUM YAG LASER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; STRATUM CORNEUM;

ADMINISTRATION, TOPICAL; ANTIMETABOLITES, ANTINEOPLASTIC; BOWEN'S DISEASE; COMBINED MODALITY THERAPY; FLUOROURACIL; HUMANS; LASERS; MALE; MIDDLE AGED; SKIN NEOPLASMS;

EID: 1942504370     PISSN: 10760512     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2004.30122.x     Document Type: Article

References (24)

1. Shupack JK, Lai IW, Washenik K. Topical cytotoxic agents. In: Freedberg IM, Eisen AZ, Wolff K, et al., eds. Dermatology in General Medicine, 5th ed. New York: McGraw-Hill, 1999:2768.
2. Miller E. The metabolism and pharmacology of 5-fluorouracil. J Surg Oncol 1971;3:309-15.
3. Meidan VM, Walmsley AD, Docker MF, Irwin WJ. Ultrasound-enhanced diffusion into coupling gel during phonophoresis of 5-fluorouracil. Int J Pharm 1999;185:205-13.
4. Lee WR, Shen SC, Wang KH, et al. The effect of laser treatment on skin to enhance and control transdermal delivery of 5-fluorouracil. J Pharm Sci 2002;91:1613-26.
5. Fulton JE, Carter DM, Hurley HJ. Treatment of Bowen's disease with topical 5-fluorouracil under occlusion. Arch Dermatol 1968;97:178-80.
6. Welch ML, Grabski WJ, McCollough ML, et al. 5-Fluorouracil iontophoretic therapy for Bowen's disease. J Am Acad Dermatol 1997;36:956-8.
7. Beall HD, Sloan KB. Topical delivery of 5-fluorouracil (5-FU) by 1,3-bisalkylcarbonyl-5-FU prodrugs. Int J Pharm 2002;231:43-9.
8. Romagosa R, Saap L, Givens M, et al. A pilot study to evaluate the treatment of basal cell carcinoma with 5-fluorouracil using phosphatidyl choline as a transdermal carrier. Dermatol Surg 2000;26:338-40.
9. Lee WR, Shen SC, Lai HH, et al. Transdermal drug delivery enhanced and controlled by erbium:YAG laser: a comparative study of lipophilic and hydrophilic drugs. J Control Release 2001;75:155-66.
10. Jacques SL, McAuliffe DJ, Blank IH, Parrish JA. Controlled removal of human stratum corneum by pulsed laser. J Invest Dermatol 1987;88:88-93.
11. 2 laser and the erbium:YAG laser: an in vivo study. Laser Surg Med 1999;24:93-102.
12. Cox NH, Eedy DJ, Morton CA. Guidelines for management of Bowen's disease. Br J Dermatol 1999;141:633-41.
13. Gordon KB, Garden JM, Robinson JK. Bowen's disease of the distal digit: outcome of treatment with carbon dioxide laser vaporization. Dermatol Surg 1996;22:723-8.
14. Humphreys TR, Malhotra R, Scharf MJ, et al. Treatment of superficial basal cell carcinoma and squamous cell carcinoma in situ with a high-energy pulsed carbon dioxide laser. Arch Dermatol 1998;134:1247-52.
15. Jones CM, Mang T, Cooper M, et al. Photodynamic therapy in the treatment of Bowen's disease. J Am Acad Dermatol 1992;27:979-82.
16. Gross G, Roussaki A, Papendick U. Efficacy of interferons on bowenoid papulosis and other precancerous lesions. J Invest Dermatol 1990;95:152S-7S.
17. Mackenzie-Wood A, de Kossard S, Launey J, et al. Imiquimod 5% cream in the treatment of Bowen's disease. J Am Acad Dermatol 2001;44:462-70.
18. Thestrup-Pedersen K, Ravnborg L, Reymann F, Morbus Bowen. A description of the disease in 617 patients. Acta Derm Venereol 1988;68:236.
19. Morton CA, Whitehurst C, Moseley H, et al. Comparison of photodynamic therapy with cryotherapy in the treatment of Bowen's disease. Br J Dermatol 1996;135:766-71.
20. Tolia BM, Castro VL, Mouded IM, Newman HR. Bowen's disease of shaft of penis: successful treatment with 5-fluorouracil. Urology 1976;7:617-9.
21. Sturm HM. Bowen's disease and 5-fluorouracil. J Am Acad Dermatol 1979;1:513-22.
22. Kirkham N. Tumors and cysts of the epidermis. In: Elder D, Elenitsas R, Jaworsky C, et al., eds. Lever's Histopathology of the Skin, 8th ed. Philadelphia: Lippincott-Raven, 1997:708.
23. Finn BC, Morgan TM. Transdermal penetration enhancers: applications, limitations, and potential. J Pharm Sci 1999;88:955-8.
24. Yun PL, Tachihara R, Anderson RR. Efficacy of erbium: yttrium-aluminum-garnet laser-assisted delivery of topical anesthetic. J Am Acad Dermatol 2002;47:542-7.